A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease

Clinical trial NCT07571746 · RECRUITING

Trial details

NCT number: NCT07571746
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Membranous Nephropathy

Start date: 2026-03-28
Primary completion: 2028-04-24
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.